Loading...
EssilorLuxottica SA
ESLOF•PNK
Healthcare
Medical - Instruments & Supplies
$279.08
$3.08(1.12%)
EssilorLuxottica SA (ESLOF) Financial Performance & Statements
Review EssilorLuxottica SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.38%
↑ 4.38%
Operating Income Growth
8.56%
↑ 8.56%
Net Income Growth
3.06%
↑ 3.06%
Operating Cash Flow Growth
0.27%
↑ 0.27%
Operating Margin
12.96%
↑ 12.96%
Gross Margin
62.91%
↑ 62.91%
Net Profit Margin
8.88%
↑ 8.88%
ROE
5.78%
↑ 5.78%
ROIC
6.24%
↑ 6.24%
EssilorLuxottica SA (ESLOF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for EssilorLuxottica SA stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $13.22B | $13.29B | $12.54B | $6.27B |
| Cost of Revenue | $5.05B | $4.88B | $4.70B | $2.40B |
| Gross Profit | $8.17B | $8.41B | $7.85B | $3.87B |
| Gross Profit Ratio | $0.62 | $0.63 | $0.63 | $0.62 |
| R&D Expenses | $184.00M | $446.00M | $293.00M | $215.00M |
| SG&A Expenses | $6.34B | $6.13B | $6.15B | $3.007B |
| Operating Expenses | $6.66B | $6.46B | $6.44B | $3.21B |
| Total Costs & Expenses | $11.71B | $11.35B | $11.14B | $5.61B |
| Interest Income | $0.00 | $0.00 | $55.00M | $26.00M |
| Interest Expense | $0.00 | $79.00M | $108.00M | $0.00 |
| Depreciation & Amortization | $2.07B | $1.03B | $1.49B | $283.50M |
| EBITDA | $3.63B | $3.00B | $2.90B | $1.009B |
| EBITDA Ratio | $0.27 | $0.23 | $0.23 | $0.16 |
| Operating Income | $1.50B | $1.94B | $1.41B | $725.50M |
| Operating Income Ratio | $0.11 | $0.15 | $0.11 | $0.12 |
| Other Income/Expenses (Net) | -$74.00M | -$83.00M | -$768.50M | -$34.50M |
| Income Before Tax | $1.43B | $1.86B | $1.28B | $637.50M |
| Income Before Tax Ratio | $0.11 | $0.14 | $0.10 | $0.10 |
| Income Tax Expense | $372.00M | $428.00M | $287.00M | $143.50M |
| Net Income | $994.00M | $1.36B | $928.00M | $464.00M |
| Net Income Ratio | $0.08 | $0.10 | $0.07 | $0.07 |
| EPS | $2.15 | $3.02 | $2.05 | $1.03 |
| Diluted EPS | $2.15 | $2.98 | $2.05 | $1.03 |
| Weighted Avg Shares Outstanding | $461.78M | $452.08M | $452.03M | $451.92M |
| Weighted Avg Shares Outstanding (Diluted) | $461.42M | $458.60M | $453.13M | $452.36M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan